Oren Fuerst, Ph.D
CEO/ Chairman/ Co-founder
Serial entrepreneur, inventor and co-founder of multiple medtech companies, including multiple exits. Vast experience in remote care and diagnostics in both the private and public sectors. Former faculty at the Yale International Center of Finance and Columbia Business School (head of the technology strategy and valuation program). Had published multiple books and articles about entrepreneurship and finance.
Experienced in bringing from concept to market innovations combining biology and digital health, including some highly relevant platforms: 1) the creation of a biodefense vaccination platform used by governments post-9/11; 2) remote diagnostics and chronic diseases management platforms and 3) Smartphone connected self-care diagnostics. His Masters and Ph.D. degrees are from Columbia Business School.
Professor Naama Geva-Zatorsky, Ph.D.
Chief Scientist/ Co-founder
Heads the Geva-Zatorsky lab at the Technion Integrated Cancer Center at the Ruth and Bruce Rappaport Faculty of Medicine, and is also affiliated with the Russell Berrie Nanotechnology Institute at the Technion.
Naama is combining systems-biology with microbiology and immunology. She is a recipient of the Alon Fellowship, the national and international UNESCO-L’Oreal award, the Human Frontiers fellowship, the EMBO fellowship, the John F. Kennedy Prize, the Teva Prize, and the Barenholz prize, for academic excellence. Naama received her B.Sc. from Tel Aviv University, double-majoring in Chemistry and Biology, with summa cum laude honors. Her M.Sc. and Ph.D., are from the Weizmann Institute, studying systems-biology of protein dynamics in cancer, with Prof. Uri Alon, completed with honors. Her postdoctoral training was at Harvard Medical School.
Professor Christopher Mason, Ph.D
COVID-19 and RT-LAMP Expert
World leader in COVID-19 diagnostic and RT-LAMP. Director of the WorldQuant Initiative for Quantitative Prediction. A faculty member at the Weill Cornell Medical Center in New-York, where he a member at both: the Institute for Computational Biomedicine (ICB); the Department of Physiology, Biophysics and Systems Biology (PBSB); Institute for Computational Biomedicine; the Brain & Mind Institute and the Meyer Cancer Center.
Among his areas of research: New biochemical and computational methods in functional genomics; novel techniques in next-generation sequencing; algorithms for tumor evolution, genome evolution, DNA and RNA modifications; algorithms for genome/epigenome engineering.
Software Development Expert
Tal is CEO & Co-Founder (with Oren Fuerst) of Medivizor , a leading a personalized health information company. Tal has over 25 years of technologies and software development experience, and has held management positions in R&D and Product Management at Amdocs, XACCT, DarioHealth (which Oren Fuerst co-founded and led) and other companies. As Amdocs’ Chief Scientist, Tal led all innovation activities across Amdocs (a public $3B company with over 20,000 employees), including a variety of innovation and incubation programs. Tal has over 30 patents to his credit, and is recognized for his passion for, and expertise in innovation by frequently being asked to speak at major industry events. He has been actively in industry consortiums including IETF, ATIS and TM Forum, serving on various committees and boards.
Professor Andres Bendesky, Ph.D.
Andrés Bendesky, M.D., Ph.D, is an expert in molecular diagnostics. He attended medical school at the Universidad Nacional Autónoma de México (UNAM). He graduated at the top of his class of 1,000 for which he received the highest student award of UNAM, the Gabino Barreda Medal. Dr. Bendesky pursued his Ph.D at The Rockefeller University. His postdoctoral work had been at Harvard University as a Helen Hay Whitney–Howard Hughes Medical Institute Fellow. In 2017 Dr. Bendesky joined Columbia as faculty, where he continues to focus on discovering genetic and neuronal mechanisms leading to diversity of social behaviors within species and across species. For his scientific achievements and promise, Dr. Bendesky has been awarded a Searle Scholarship, a Klingenstein-Simons Neuroscience Fellowship, and a Sloan Research Fellowship in Neuroscience.
Professor Noam Shomron, Ph.D.
A world leader in bioinformatics. Heads the Shomron research laboratory at the Faculty of Medicine at Tel Aviv University, focusing on the analysis of genomic data in order to understand human diseases. Combining high-throughput methods and bioinformatics (such as AI and deep learning), his team's research explores DNA changes and gene regulators. Trained at MIT. Co‐founder and Scientific Director of the Functional Genomics Laboratory at Tel Aviv University. Co-founder of multiple life sciences companies.
Professor Ezri Tarazi
Industrial Design Expert
Professor Ezri Tarazi is the Chair of the Industrial Design Program at the Faculty of Architecture and Town Planning at the Technion. He is also the chair of t-Hub, a new center for innovation and entrepreneurship at the Technion, and chair of Design-Tech Lab, which seeks to foster design awareness and design thinking among science and engineering students.
He is the former Chair of the Industrial Design department at Bezalel. He co-founded IDEO branch in Israel, Keter’s d- Vision and the Tarazi Studio. Had received multiple national and international awards including the Red dot awards, and ID awards. He is a member of the Israeli Council for Higher Education and chaired the Supreme Committee for the Humanities, Arts, Education, and Pedagogy.